.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Chinese Patent Office
Baxter
Boehringer Ingelheim
Harvard Business School
Fuji
US Department of Justice
Julphar
QuintilesIMS

Generated: February 21, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 97203568

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Janssen PharmsINVEGA SUSTENNApaliperidone palmitateSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264-001Jul 31, 2009RXYesNo➤ Sign Up➤ Sign UpY
Janssen PharmsINVEGA SUSTENNApaliperidone palmitateSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264-002Jul 31, 2009RXYesNo➤ Sign Up➤ Sign UpY
Janssen PharmsINVEGA SUSTENNApaliperidone palmitateSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264-003Jul 31, 2009RXYesNo➤ Sign Up➤ Sign UpY
Janssen PharmsINVEGA SUSTENNApaliperidone palmitateSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264-004Jul 31, 2009RXYesYes➤ Sign Up➤ Sign UpY
Janssen PharmsINVEGA SUSTENNApaliperidone palmitateSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264-005Jul 31, 2009RXYesNo➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist